2024
Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA vs. attenuated whole-virus vaccines
Adin M, Isufi E, Wu J, Pang Y, Nguyen D, Has D, Caner C, Aboueldaha N, Mossa-Basha M, Pucar D. Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA vs. attenuated whole-virus vaccines. Nuclear Medicine Communications 2024, 45: 474-480. PMID: 38465449, DOI: 10.1097/mnm.0000000000001833.Peer-Reviewed Original ResearchAxillary lymph nodesWhole virus vaccineLymph nodesMRNA vaccinesNatural courseValue of clinical parametersCOVID-19 mRNA vaccinesPredictive value of clinical parametersDose of vaccine administrationPET-CT studiesCohort of oncology patientsDeauville criteriaPET criteriaClinical parametersYounger patientsSingle doseModerna recipientsJ&J vaccinePET-positiveMultivariate analysisVaccine typesOncology patientsPredictive valueVaccine administrationModerna vaccine
2016
Detection of incidental pulmonary embolism with multi-slice computed tomography in cancer patients
Deniz M, Deniz Z, Adin M, Akıl F, Turmak M, Urakcı Z, Cetincakmak M, Goya C. Detection of incidental pulmonary embolism with multi-slice computed tomography in cancer patients. Clinical Imaging 2016, 41: 106-111. PMID: 27840261, DOI: 10.1016/j.clinimag.2016.10.018.Peer-Reviewed Original ResearchConceptsLower lobe branchesIncidental pulmonary embolismRight pulmonary arteryBreast cancer groupFinal radiology reportPositive patientsPulmonary emboliPulmonary embolismOncology patientsPulmonary arteryCancer groupCancer patientsPrimary tumorRisk factorsOncological patientsCommon locationPatientsRadiology reportsHigher proportionEmbolismEmboliArteryTumors